M&A - Ensysce Biosciences, Inc.

Form Type: 8-K

Filing Date: 2025-06-05

Corporate Action: Merger

Type: Update

Accession Number: 000164117225013853

Filing Summary: On June 3, 2025, Ensysce Biosciences, Inc. was notified that Moss Adams LLP, the Company’s independent registered public accounting firm, merged with Baker Tilly US, LLP. Following this merger, Moss Adams resigned as the auditors of the Company, and the Audit Committee approved the appointment of Baker Tilly as the successor. The audit reports from Moss Adams were not adverse or modified, but included an explanatory paragraph regarding going concern uncertainty. Throughout the years ending December 31, 2024 and 2023, there were no disagreements with Moss Adams, nor were there reportable events requiring disclosure. The Company did not consult with Baker Tilly on any accounting matters prior to this report. A letter from Moss Adams regarding its agreement with this statement is filed as Exhibit 16.1 to this Form 8-K.